Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 199.2 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 244.72.
  • The stock is close to a major daily resistance at USD 244.72, which should be gotten rid of so as to gain new appreciation potential.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 43.83 times its estimated earnings per share for the ongoing year.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
ILLUMINA11.47%35 558
THERMO FISHER SCIENTIFIC12.44%85 167
DANAHER8.34%69 950
INTUITIVE SURGICAL18.71%48 542
ROYAL PHILIPS6.48%38 614
BOSTON SCIENTIFIC CORPORATI..11.54%37 969
EDWARDS LIFESCIENCES9.94%26 222
AGILENT TECHNOLOGIES9.11%23 516
CERNER2.26%22 907
WATERS CORPORATION9.07%16 759
OLYMPUS CORP-4.21%13 017
RESMED4.71%12 584
RESMED INC. (CHESS)1.00%12 571
HOLOGIC1.66%11 981
VARIAN MEDICAL SYSTEMS-0.75%10 107
ABIOMED, INC.21.81%10 094
More Results
Financials ($)
Sales 2017 2 725 M
EBIT 2017 656 M
Net income 2017 817 M
Finance 2017 809 M
Yield 2017 -
P/E ratio 2017 43,83
P/E ratio 2018 58,48
EV / Sales 2017 12,8x
EV / Sales 2018 11,0x
Capitalization 35 558 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ILLUMINA
Duration : Period : Day
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Duration : Period : Week
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders